Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Human-Centered Design Development and Acceptability Testing of a Goal Concordant Prescribing Program in Hospice.
Fibrinogens, Abnormal
Vascular Endothelial Growth Factor Receptor-2
Bacterial Toxins
Identification of genetic risk for pancreatic adenocarcinoma.
See All 10 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Identification of genetic risk for pancreatic adenocarcinoma.
Flores K, Dinh K, Rouleau E, Whalen G, Wassef W, LaFemina J. Identification of genetic risk for pancreatic adenocarcinoma. Cancer Genet. 2015 Nov; 208(11):559-63.
View in:
PubMed
subject areas
Carcinoma, Pancreatic Ductal
Early Detection of Cancer
Genetic Predisposition to Disease
Genetic Testing
Humans
Mutation
Pancreatic Neoplasms
Pancreatitis, Chronic
Retrospective Studies
Risk Factors
authors with profiles
Giles Whalen MD
Jennifer LaFemina MD
Kate Hui Dinh MD, MS